Poliovirus Infection in Children

Introduction to Poliovirus Infection in Children

Poliomyelitis, commonly known as polio, is a highly infectious viral disease caused by the poliovirus. It primarily affects children under the age of 5 but can impact individuals of any age who are not immunized. The disease has been largely eradicated in most parts of the world due to widespread vaccination efforts, but it remains endemic in a few countries.

Poliovirus is a member of the Enterovirus genus in the Picornaviridae family. There are three serotypes of wild poliovirus (types 1, 2, and 3), each capable of causing paralysis. Type 2 wild poliovirus was declared eradicated in 2015, and type 3 in 2019. Currently, only type 1 wild poliovirus remains in circulation in endemic countries.

Etiology of Poliovirus Infection

Poliovirus is a single-stranded RNA virus belonging to the Enterovirus genus. Key characteristics include:

  • Non-enveloped icosahedral structure
  • Approximately 30 nm in diameter
  • Three serotypes: PV1, PV2, and PV3
  • Highly stable in the environment, resistant to common disinfectants

The virus primarily infects humans through the fecal-oral route, with occasional transmission via respiratory droplets. It replicates in the gastrointestinal tract before potentially invading the central nervous system.

Epidemiology of Poliovirus Infection

Poliovirus infection has seen a dramatic decline globally due to widespread vaccination efforts:

  • In 1988, wild poliovirus was endemic in 125 countries
  • As of 2023, wild poliovirus remains endemic only in Afghanistan and Pakistan
  • Cases have decreased by over 99% since 1988, from an estimated 350,000 cases to 33 reported cases in 2018

Risk factors for infection include:

  • Lack of immunization
  • Living in or traveling to areas with poor sanitation
  • Age (children under 5 are most at risk)
  • Immunodeficiency

Seasonality: In temperate climates, poliovirus infections peak in summer and early autumn. In tropical areas, there is no seasonal pattern.

Pathophysiology of Poliovirus Infection

The pathophysiology of poliovirus infection involves several stages:

  1. Entry and Initial Replication: The virus enters the body via the oral or respiratory route and initially replicates in the pharynx and gastrointestinal tract.
  2. Viremia: The virus enters the bloodstream, leading to a primary viremia. This can result in flu-like symptoms.
  3. CNS Invasion: In a small percentage of cases, the virus crosses the blood-brain barrier and invades the central nervous system.
  4. Neural Damage: The virus preferentially infects and destroys motor neurons in the anterior horn of the spinal cord and brainstem. This leads to the characteristic flaccid paralysis associated with poliomyelitis.
  5. Muscle Atrophy: Destruction of motor neurons results in denervation and subsequent atrophy of the affected muscles.

The severity of the disease depends on the extent of CNS involvement and the specific areas affected. Bulbar poliomyelitis, involving the brainstem, can lead to respiratory failure and is potentially life-threatening.

Clinical Presentation of Poliovirus Infection

The clinical manifestations of poliovirus infection can be categorized into four forms:

  1. Asymptomatic Infection (72% of cases):
    • No clinical symptoms
    • Individuals can still shed the virus and infect others
  2. Abortive Poliomyelitis (24% of cases):
    • Mild, nonspecific symptoms lasting 2-3 days
    • Fever, sore throat, headache, vomiting, fatigue, and muscle pain
  3. Non-paralytic Poliomyelitis (1-5% of cases):
    • Aseptic meningitis
    • Stiff neck, back pain, and muscle spasms
    • Symptoms last for 2-10 days
  4. Paralytic Poliomyelitis (<1% of cases):
    • Acute onset of flaccid paralysis
    • Asymmetric paralysis, predominantly affecting the lower limbs
    • Deep tendon reflexes are diminished or absent
    • Sensory function remains intact
    • Bulbar involvement may lead to difficulty swallowing and breathing

The incubation period for poliovirus infection ranges from 3 to 35 days, with an average of 7-10 days before the onset of paralysis in severe cases.

Diagnosis of Poliovirus Infection

Diagnosis of poliovirus infection involves clinical assessment, laboratory tests, and imaging studies:

  1. Clinical Diagnosis:
    • Based on symptoms and physical examination
    • Acute flaccid paralysis (AFP) is a key indicator
  2. Laboratory Tests:
    • Virus isolation from stool samples or throat swabs
    • PCR detection of viral RNA
    • Serological tests for poliovirus-specific antibodies
  3. Cerebrospinal Fluid (CSF) Analysis:
    • Elevated protein levels
    • Normal or slightly elevated cell count (predominantly lymphocytes)
  4. Imaging Studies:
    • MRI: May show increased signal intensity in the anterior horn cells of the spinal cord
    • EMG: Can help differentiate polio from other causes of acute flaccid paralysis

Differential diagnosis includes other causes of acute flaccid paralysis such as Guillain-Barré syndrome, transverse myelitis, and botulism.

Treatment of Poliovirus Infection

There is no specific antiviral treatment for poliovirus infection. Management is primarily supportive and focuses on alleviating symptoms and preventing complications:

  1. Supportive Care:
    • Rest and pain management
    • Proper nutrition and hydration
    • Physical therapy to prevent deformities and improve muscle function
  2. Respiratory Support:
    • Mechanical ventilation may be necessary for patients with bulbar poliomyelitis
    • Regular monitoring of respiratory function
  3. Management of Complications:
    • Treatment of secondary bacterial infections
    • Prevention and management of pressure sores
    • Psychological support for patients and families
  4. Rehabilitation:
    • Long-term physical and occupational therapy
    • Orthotic devices and assistive technologies as needed

The prognosis for patients with paralytic poliomyelitis varies. Some may recover completely, while others may have permanent paralysis. Post-polio syndrome can occur decades after the initial infection in some survivors.

Prevention of Poliovirus Infection

Prevention of poliovirus infection primarily relies on vaccination and public health measures:

  1. Vaccination:
    • Inactivated Polio Vaccine (IPV): Injectable, contains killed virus
    • Oral Polio Vaccine (OPV): Contains live attenuated virus, no longer used in many developed countries due to rare risk of vaccine-associated paralytic poliomyelitis
    • Routine childhood immunization schedule: typically 4 doses of IPV at 2 months, 4 months, 6-18 months, and 4-6 years
  2. Global Eradication Efforts:
    • WHO's Global Polio Eradication Initiative (GPEI)
    • Mass immunization campaigns in endemic and high-risk areas
    • Surveillance for acute flaccid paralysis cases
  3. Sanitation and Hygiene:
    • Improved water quality and sanitation facilities
    • Proper hand hygiene practices
  4. Travel Precautions:
    • Vaccination recommendations for travelers to endemic areas
    • International health regulations to prevent spread across borders

The success of these prevention strategies has brought the world close to polio eradication, with only a few remaining endemic countries.

Complications of Poliovirus Infection

Poliovirus infection can lead to various acute and long-term complications:

  1. Acute Complications:
    • Respiratory failure due to paralysis of respiratory muscles
    • Aspiration pneumonia
    • Urinary tract infections due to bladder paralysis
    • Myocarditis
    • Gastrointestinal paralysis leading to ileus
  2. Long-term Complications:
    • Permanent paralysis and muscle atrophy
    • Skeletal deformities (e.g., scoliosis, limb length discrepancies)
    • Chronic pain
    • Osteoporosis due to immobility
  3. Post-Polio Syndrome (PPS):
    • Occurs 15-40 years after initial infection
    • Symptoms include new muscle weakness, fatigue, and pain
    • May affect 25-40% of polio survivors
  4. Psychological Impact:
    • Depression and anxiety related to disability
    • Social isolation
    • Reduced quality of life

Early recognition and management of these complications are crucial for improving outcomes and quality of life for polio survivors.



Poliovirus Infection in Children
  1. What is the causative agent of poliomyelitis?
    Poliovirus (an enterovirus)
  2. How many serotypes of poliovirus exist?
    Three (Types 1, 2, and 3)
  3. What is the primary mode of transmission for poliovirus?
    Fecal-oral route
  4. Which age group is most susceptible to poliovirus infection?
    Children under 5 years old
  5. What percentage of poliovirus infections are asymptomatic?
    Approximately 72%
  6. Which part of the nervous system does poliovirus primarily affect?
    Anterior horn cells of the spinal cord
  7. What is the incubation period for poliomyelitis?
    7-14 days (range: 3-35 days)
  8. Which of the following is NOT a common symptom of non-paralytic poliomyelitis?
    Seizures
  9. What is the term for the muscle weakness and pain that occurs years after the initial poliovirus infection?
    Post-polio syndrome
  10. Which type of vaccine is used in the oral polio vaccine (OPV)?
    Live attenuated poliovirus
  11. What is the recommended number of OPV doses in the primary vaccination series?
    Three doses
  12. Which type of poliovirus was declared eradicated globally in 2015?
    Wild poliovirus type 2
  13. What is the name of the global initiative launched in 1988 to eradicate polio?
    Global Polio Eradication Initiative (GPEI)
  14. Which of the following is a potential complication of oral polio vaccine?
    Vaccine-associated paralytic poliomyelitis (VAPP)
  15. What is the preferred method for diagnosing acute poliovirus infection?
    Isolation of poliovirus from stool samples
  16. Which of the following is NOT a risk factor for developing paralytic poliomyelitis?
    Breastfeeding
  17. What is the term for the temporary form of paralysis that can occur in poliomyelitis?
    Transient paralysis
  18. Which type of immunity is most effective in preventing poliovirus infection?
    Mucosal immunity
  19. What is the recommended treatment for paralytic poliomyelitis?
    Supportive care (no specific antiviral treatment)
  20. Which country was declared polio-free most recently (as of 2020)?
    Nigeria
  21. What is the name of the poliovirus strain derived from the oral polio vaccine that can cause outbreaks?
    Circulating vaccine-derived poliovirus (cVDPV)
  22. Which type of cells does poliovirus primarily infect?
    Motor neurons
  23. What is the recommended interval between OPV doses in the primary series?
    4 weeks
  24. Which of the following is a contraindication for OPV administration?
    Severe combined immunodeficiency (SCID)
  25. What is the term for the condition where poliovirus is detected in sewage but no cases are reported?
    Environmental surveillance positive
  26. Which organ system, other than the nervous system, can be affected in bulbar poliomyelitis?
    Respiratory system
  27. What is the maximum duration of viral shedding in stool after OPV administration?
    Up to 6 weeks
  28. Which type of poliovirus is considered the most neurovirulent?
    Type 1
  29. What is the name of the polio endgame strategy that involves switching from trivalent OPV to bivalent OPV?
    The Polio Endgame Strategy 2019-2023
  30. Which vitamin deficiency has been associated with increased susceptibility to poliovirus infection?
    Vitamin C deficiency
  31. What is the term for the condition where a person has antibodies against poliovirus but can still be infected and transmit the virus?
    Mucosal immunity gap
  32. Which of the following is NOT a typical CSF finding in poliomyelitis?
    High protein with normal cell count


External Links for Further Reading
Powered by Blogger.